Bayer CEO says recovery on track as key drug products shine There were also modest gains for the company's consumer health and crop science divisions, although restructuring costs dragged down earnings by 16.5% to €2.11 billion. Among pharma watchers ... 10/30/2024 - 1:00 pm | View Link
10 Years of NextGen Honorees: Where Are They Now? BioSpace has been compiling a list of the most innovative and exciting biotechs for a decade. Here we take a look back at noteworthy companies from each of those lists. 10/29/2024 - 5:34 pm | View Link
Novartis Beats on Q3 Earnings and Sales, Raises 2024 Outlook Swiss pharma giant Novartis AG NVS reported better-than-expected results for the third quarter of 2024. Core earnings (excluding one-time charges) of $2.06 per share beat the Zacks Consensus Estimate ... 10/29/2024 - 3:23 am | View Link
Pfizer raises full-year guidance, beats Q3 estimates; shares climb Pfizer (NYSE:PFE) shares climbed around 2% in premarket trading Tuesday after the pharma giant raised earnings and revenue guidance for fiscal 2024 and beat Q3 results estimates. The company reported ... 10/29/2024 - 12:55 am | View Link
Moody's raises full-year profit forecast above estimates on strong product demand Ratings agency Moody's raised its full-year adjusted profit forecast above Wall Street estimates and posted a nearly 31% rise in third-quarter earnings on Tuesday, on strong demand for its research ... 10/22/2024 - 12:11 am | View Link
History shows that businesses that don’t stand up to political leaders suffer the consequences.
In October, Trump’s allies threatened to terminate Deloitte’s government contracts—worth about $3 billion annually—if Trump is elected to a second term. Why? Because one of their 457,000 employees made old messages with JD Vance public. As part of his authoritarian playbook for 2025, Trump has pledged to wield the power of government against his perceived enemies, such as by directing the Justice Department to prosecute opponents and the Federal Communications Commission to revoke broadcast licenses.
The Harris campaign proposed policies and programs to uplift new startups—community leaders should get on board, too.
With less than a week remaining before the 2024 election, one of the biggest tragedies unfolding in the U. S. is the overshadowing of vital issues by polarization. As a country, we’ve historically faced division across different areas, whether economically or socially, which is to be expected.
Women are now in a position to solve female-related problems with products at mass scale. Two new books bring the rising femtech category into the mainstream.
Over the past decade, there has been an explosion of startup activity addressing issues of the “female” sort. For the first time in history, women at a mass scale have the power to create businesses to solve their problems.
A new material developed at UC Berkeley could help bring down the cost of capturing carbon dioxide from the air.
Earlier this year, scientists at the University of California, Berkeley, filled a device with bright-yellow powder, connected it to a tube, and stuck the tube through the wall of a lab.
By the 1800s, the Day of the Dead markets in Mexico City were also selling clothing, shoes, furniture, tools, home decor, and many other things.
As a Mexican-American who celebrates Día de los Muertos, or the Day of the Dead, at the end of October and beginning of November, I’ve noted an increasing concern the past several years that the holiday is becoming more commercialized.
Highway expansions emit a lot of carbon in their production.
California prides itself on its climate leadership. And the state’s work on transportation—its largest source of emissions—is no exception; its electric vehicle policies have been adopted by other states across the country. Sacramento lawmakers have also taken ambitious steps to reduce car use altogether, developing regulations aimed at reshaping communities to encourage walking, biking, and taking public transportation.